Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2018 07:30 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: aktietilbagekøbsprogram

Bagsværd, 2018-01-08 - Den 1. november 2017 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og Rådets forordning (EU) nr. 596/2014 af 16....
January 08, 2018 07:30 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Share repurchase programme

Bagsværd, Denmark, 8 January 2018 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and...
January 08, 2018 00:30 ET | Source: Novo Nordisk A/S

Novo Nordisk har foreslået at erhverve Ablynx for op til 30,50 EUR pr. aktie i kontant vederlag, heraf 28,00 EUR ved overtagelsen og €2,50 i betingede vederlagsrettigheder (Contingent Value Rights)

Forslaget omfatter en kontant betaling ved overtagelsen på 28,00 EUR pr. aktie og en betinget vederlagsrettighed (Contingent Value Right eller 'CVR') med samlede kontante betalinger over tid på...
January 08, 2018 00:30 ET | Source: Novo Nordisk A/S

Novo Nordisk has proposed to acquire Ablynx for up to EUR 30.50 per share in cash, consisting of EUR 28.00 upfront and EUR 2.50 in Contingent Value Rights

Proposal consists of upfront cash consideration of EUR 28.00 per share and one Contingent Value Right ('CVR') with total potential cash payments over time of up to EUR 2.50 per share Opportunity to...
January 02, 2018 05:14 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Status vedrørende Novo Nordisks beholdning af egne aktier (31. december 2017)

Bagsværd, 2018-01-02 - I forlængelse af selskabets meddelelser af 9. august 2017 og 1. november 2017 om planlagte aktietilbagekøbsprogrammer samt i henhold til New York Stock Exchange Listed Company...
January 02, 2018 05:14 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 December 2017)

Bagsværd, Denmark, 2 January 2018 - In continuation of the company's announcements dated 9 August 2017 and 1 November 2017 concerning planned share repurchase programmes, and pursuant to Section...
December 27, 2017 05:42 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Aktietilbagekøbsprogram

Bagsværd, 2017-12-27 - Den 1. november 2017 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og Rådets forordning (EU) nr. 596/2014 af 16....
December 27, 2017 05:42 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Share repurchase programme

Bagsværd, Denmark, 27 December 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and...
December 18, 2017 08:21 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Aktietilbagekøbsprogram

Bagsværd, 2017-12-18 - Den 1. november 2017 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og Rådets forordning (EU) nr. 596/2014 af 16....
December 18, 2017 08:21 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: Share repurchase programme

Bagsværd, Denmark, 18 December 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and...